7 Related guidance
7.1 NICE has issued the following related guidance.
Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NICE technology appraisal guidance 93 (2005).[Replaced by NICE clinical guideline 131]
Improving outcomes in colorectal cancers: manual update. NICE cancer service guidance (2004).
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. NICE technology appraisal guidance 61 (2003).